<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04224597</url>
  </required_header>
  <id_info>
    <org_study_id>Hitit University</org_study_id>
    <nct_id>NCT04224597</nct_id>
  </id_info>
  <brief_title>Evaluation of the Presence of Enthesitis in Patients With Acne Vulgaris</brief_title>
  <official_title>Evaluation of the Presence of Enthesitis in Patients With Acne Vulgaris</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Erol Olcok Corum Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Erol Olcok Corum Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acne vulgaris is an inflammatory disease of the pilosebaceous unit, affecting about 85% of
      the young population. In the studies p. acne is a potent stimulator of the release of
      IFN-gamma (IFN-)) and IL-17 from CD4 + T cells, and the presence of IL-17 + cells in the
      perifollicular infiltrate has been shown in biopsies of inflammatory acne lesions. Therefore,
      acne is thought to be a Th17-related disease (1).

      This study was aimed to evaluate the presence of enthesitis in patients with acne vulgaris.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with acne vulgaris and healthy controls aged between 18-25 who admitted to Hitit
      University Erol Olcok Education and Research Hostpital Dermatology policlinic will be
      icluded. Patients with rheumatic, neurological diseases, history of trauma and previous
      fractures will be excluded from the study. After all the participants were evaluated by the
      dermatologist and demographic data will be recorded, the participants will be examined by the
      physical medicine and rehabilitation specialist and the short form-36 (sf-36), hospital
      anxiety and depression scale will be completed. Bilateral lower extremity tendon thicknesses
      and the presence of erosion, bursitis, etc. will be evaluated according to the criteria of
      Guess (Glasgow Ultrasound Enthesitis Scoring System) and Guess score will be determined for
      all participants. A total of 48 participants, 24 patients with acne vulgaris and 24 healthy
      controls, will be included in the study (2).
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 1, 2020</start_date>
  <completion_date type="Anticipated">April 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>patellar tendon thicknesses of patients with acne vulgaris and healthy controls</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Ashilles tendon thicknesses of patients with acne vulgaris and healthy controls</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Enthesitis</condition>
  <condition>Acne Vulgaris</condition>
  <condition>Ultrasonography</condition>
  <arm_group>
    <arm_group_label>Patients with acne vulgaris</arm_group_label>
    <description>patients with acne vulgaris aged between 18-25 year</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy controls</arm_group_label>
    <description>healthy controls aged between 18-25 year</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>ultrasonography</intervention_name>
    <description>all participants will be determined by ultrasonography.</description>
    <arm_group_label>Healthy controls</arm_group_label>
    <arm_group_label>Patients with acne vulgaris</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with acne vulgaris and healthy controls aged between 18-25
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteira:

          -  Patients with acne vulgaris and healthy controls aged between 18-25

        Exclusion Criteria:

          -  Participants with rheumatic and neurologic disease, history of trauma ,
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Dilek E Büyükşireci</last_name>
    <phone>+905439196253</phone>
    <email>dilekeker55@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Dilek Eker Büyükşireci</name>
      <address>
        <city>Çorum</city>
        <state>Central Anatolia</state>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 8, 2020</study_first_submitted>
  <study_first_submitted_qc>January 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 13, 2020</study_first_posted>
  <last_update_submitted>January 23, 2020</last_update_submitted>
  <last_update_submitted_qc>January 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Erol Olcok Corum Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Dilek Eker Büyükşireci</investigator_full_name>
    <investigator_title>Specialist doctor</investigator_title>
  </responsible_party>
  <keyword>enthesitis</keyword>
  <keyword>acne vulgaris</keyword>
  <keyword>Guess</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Enthesopathy</mesh_term>
    <mesh_term>Acne Vulgaris</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

